GS
Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
376
Aurora
AUR
$10.5B
|
MD
Mark Delaney
| $5.70 | $7 |
23%
upside
| Neutral |
12 May ‘25
4 months ago |
|
377
Affirm
AFRM
$28.8B
|
WN
Will Nance
| $88.42 | $58 |
34%
downside
| Buy |
12 May ‘25
4 months ago |
|
378
10x Genomics
TXG
$1.68B
|
MS
Matthew Sykes
| $13.50 | $6.50 |
52%
downside
| Sell |
12 May ‘25
4 months ago |
|
379
AB InBev
BUD
$116B
|
ON
Olivier Nicolai
| $59.31 | $88 |
48%
upside
| Buy |
12 May ‘25
4 months ago |
|
380
Warby Parker
WRBY
$3.29B
|
BR
Brooke Roach
| $26.96 | $20 |
26%
downside
| Buy |
9 May ‘25
4 months ago |
|
381
Veeco
VECO
$1.49B
|
BL
Brian Lee
| $24.81 | $20 |
19%
downside
| Neutral |
9 May ‘25
4 months ago |
|
382
Tapestry
TPR
$21.9B
|
BR
Brooke Roach
| $105.18 | $93 |
12%
downside
| Buy |
9 May ‘25
4 months ago |
|
|
SLN
383
Silence Therapeutics
SLN
$246M
|
RL
Richard Law
| $5.21 | $3 |
42%
downside
| Sell |
9 May ‘25
4 months ago |
|
384
SharkNinja
SN
$16.2B
|
BR
Brooke Roach
| $115.28 | $112 |
3%
downside
| Buy |
9 May ‘25
4 months ago |
|
385
Sensata Technologies
ST
$4.66B
|
MD
Mark Delaney
| $31.69 | $30 |
5%
downside
| Buy |
9 May ‘25
4 months ago |
|
386
Rocket Pharmaceuticals
RCKT
$346M
|
RL
Richard Law
| $3.21 | $13 |
305%
upside
| Neutral |
9 May ‘25
4 months ago |
|
387
Nutrien
NTR
$27.9B
|
DF
Duffy Fischer
| $56.45 | $59 |
5%
upside
| Sell |
9 May ‘25
4 months ago |
|
388
NCR Voyix
VYX
$1.79B
|
WN
Will Nance
| $12.98 | $11 |
15%
downside
| Neutral |
9 May ‘25
4 months ago |
|
|
INGM
389
Ingram Micro Holding Corporation
INGM
$4.8B
|
MN
Michael Ng
| $20.44 | $25 |
22%
upside
| Buy |
9 May ‘25
4 months ago |
|
390
HubSpot
HUBS
$26.5B
|
GB
Gabriela Borges
| $502.29 | $795 |
58%
upside
| Buy |
9 May ‘25
4 months ago |
|
391
GoodRx Holdings
GDRX
$1.43B
|
ES
Eric Sheridan
| $4.13 | $5 |
21%
upside
| Neutral |
9 May ‘25
4 months ago |
|
392
Fluence Energy
FLNC
$888M
|
BL
Brian Lee
| $6.78 | $8 |
18%
upside
| Buy |
9 May ‘25
4 months ago |
|
393
Expedia Group
EXPE
$26.9B
|
ES
Eric Sheridan
| $217.70 | $183 |
16%
downside
| Buy |
9 May ‘25
4 months ago |
|
394
Cogent Communications
CCOI
$1.81B
|
JS
James Schneider
| $36.30 | $62 |
71%
upside
| Neutral |
9 May ‘25
4 months ago |
|
395
Celldex Therapeutics
CLDX
$1.55B
|
RL
Richard Law
| $24.30 | $31 |
28%
upside
| Neutral |
9 May ‘25
4 months ago |
|
|
CMRC
396
Commerce.com, Inc. Series 1 Common Stock
CMRC
$376M
|
GB
Gabriela Borges
| $4.63 | $8.50 |
84%
upside
| Neutral |
9 May ‘25
4 months ago |
|
397
Applovin
APP
$189B
|
ES
Eric Sheridan
| $558.17 | $435 |
22%
downside
| Neutral |
9 May ‘25
4 months ago |
|
398
Altice USA
ATUS
$1.12B
|
JS
James Schneider
| $2.39 | $2.25 |
6%
downside
| Sell |
9 May ‘25
4 months ago |
|
399
4D Molecular Therapeutics
FDMT
$326M
|
SR
Salveen Richter
| $6.97 | $44 |
531%
upside
| Buy |
9 May ‘25
4 months ago |
|
400
Zillow
ZG
$20.3B
|
MB
Mike Burton
| $83.85 | $69 |
18%
downside
| Neutral |
8 May ‘25
4 months ago |
|